Cara Therapeutics Inc Logo Image

Cara Therapeutics Inc

Cara Therapeutics Inc Banner Image

Most Recent Annual Report

2017 Annual Report and Form 10K

Cara Therapeutics Inc

Cara Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Cara Therapeutics Inc

11-50 Employees
Based in Stamford, Connecticut

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase 2 clinical trials for the treatment acute postoperative pain in adult patients, as well as in Phase 2 clinical trials for the treatment of uremic pruritus disease.

Ticker:
CARA
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol

Filter by: